Novosteo Inc.
Pharmaceutical company · West Lafayette, Indiana, United States
Novosteo Inc. is a pharmaceutical company headquartered in West Lafayette, Indiana, United States. Its earliest recorded incorporation is in 2017. It has received 2 US government small-business research awards (SBIR/STTR) from health agencies, $2 million in total, most recently in 2019. It has reported private securities offerings to the US SEC, most recently $18 million sold in a notice filed in 2022.
Novosteo at a glance
What does Novosteo do?
US government research funding
2 SBIR/STTR small-business research awards from US health agencies, $2 million in total (2018 to 2019). NIH funding came from the National Institute of Dental and Craniofacial Research.
Private fundraising reported to the SEC
4 Form D notices; the most recent reported $17.7 million sold (2022).
Frequently asked questions about Novosteo
Where is Novosteo headquartered?
Novosteo Inc. is headquartered in West Lafayette, Indiana, United States.
What does Novosteo do?
Novosteo Inc. is a pharmaceutical company.
When was Novosteo founded?
The earliest incorporation on record for Novosteo Inc. is in 2017, according to public company registers.
Similar companies
- Endocyte IncWest Lafayette, Indiana, United States
- AbbVie Inc.North Chicago, Illinois, United States
- Savara IncAustin, Texas, United States
- Crinetics Pharmaceuticals, Inc.San Diego, California, United States
- Cartesian Therapeutics, Inc.Frederick, Maryland, United States
- Karyopharm Therapeutics Inc.Newton, Massachusetts, United States
- Dare Bioscience, Inc.San Diego, California, United States
- Cellectar Biosciences, Inc.Florham Park, New Jersey, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences